• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反应性对奥沙利铂类似物细胞积累和细胞毒性的影响。

Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

机构信息

Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, An der Immenburg 4, 53121, Bonn, Germany.

出版信息

J Biol Inorg Chem. 2012 Jun;17(5):699-708. doi: 10.1007/s00775-012-0889-9. Epub 2012 Mar 29.

DOI:10.1007/s00775-012-0889-9
PMID:22456982
Abstract

The purpose of this study was to systematically investigate the relationships between reactivity, cellular accumulation, and cytotoxicity of a panel of oxaliplatin analogues with different leaving groups in human carcinoma cells. The reactivity of the complexes towards the nucleotides 2'-deoxyguanosine 5'-monophosphate and 2'-deoxyadenosine 5'-monophosphate was studied using capillary electrophoresis. Cellular accumulation and cytotoxicity were measured in an oxaliplatin-sensitive and oxaliplatin-resistant ileocecal colorectal adenocarcinoma cell line pair (HCT-8/HCT-8ox). Platinum concentrations were determined by flameless atomic absorption spectrometry. The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used to assess cytotoxicity. Early cellular platinum accumulation was predominantly affected by lipophilicity. A relationship between reactivity and cellular accumulation was observed for three of four platinum complexes investigated, whereas the most lipophilic oxaliplatin analogue was an exception. Increased reactivity and reduced lipophilicity were associated with high cytotoxic activity. Resistance was influenced by lipophilicity but not by reactivity. The observed relationships may help in the design of analogues with high antitumoral activity in oxaliplatin-sensitive as well as oxaliplatin-resistant cells.

摘要

本研究旨在系统地研究一组具有不同离去基团的奥沙利铂类似物在人类癌细胞中的反应性、细胞内积累和细胞毒性之间的关系。使用毛细管电泳研究了配合物对核苷酸 2'-脱氧鸟苷 5'-单磷酸和 2'-脱氧腺苷 5'-单磷酸的反应性。在奥沙利铂敏感和奥沙利铂耐药回盲结直肠腺癌细胞系对(HCT-8/HCT-8ox)中测量了细胞内积累和细胞毒性。通过无火焰原子吸收光谱法测定了铂浓度。使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基-2H-四唑溴盐(MTT)测定法评估细胞毒性。早期细胞内铂积累主要受亲脂性影响。对于研究的四种铂配合物中的三种,观察到反应性和细胞内积累之间存在关系,而最亲脂性的奥沙利铂类似物是一个例外。增加的反应性和降低的亲脂性与高细胞毒性活性相关。耐药性受亲脂性影响,但不受反应性影响。观察到的关系可能有助于设计在奥沙利铂敏感和奥沙利铂耐药细胞中具有高抗肿瘤活性的类似物。

相似文献

1
Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.反应性对奥沙利铂类似物细胞积累和细胞毒性的影响。
J Biol Inorg Chem. 2012 Jun;17(5):699-708. doi: 10.1007/s00775-012-0889-9. Epub 2012 Mar 29.
2
Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?提高亲脂性作为克服铂类化合物耐药性的策略?
J Inorg Biochem. 2011 May;105(5):709-17. doi: 10.1016/j.jinorgbio.2011.02.005. Epub 2011 Feb 19.
3
Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.大分子铂配合物在顺铂耐药肿瘤细胞中的细胞蓄积及细胞毒性
J Control Release. 2008 Oct 21;131(2):100-6. doi: 10.1016/j.jconrel.2008.07.017. Epub 2008 Jul 18.
4
Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.在同源结肠癌细胞中,获得性耐药对奥沙利铂的药物蓄积减少比顺铂更重要。
Anticancer Drugs. 2010 Jun;21(5):523-31. doi: 10.1097/CAD.0b013e328337b867.
5
trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.反式、顺式、顺式-双(苯甲酸根)二氯(环己烷-1R,2R-二胺)铂(IV):一种用于治疗奥沙利铂难治性结直肠癌的前体药物候选物。
ChemMedChem. 2014 Jun;9(6):1299-305. doi: 10.1002/cmdc.201400061. Epub 2014 Apr 8.
6
Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.四唑桥联双核铂(II)配合物的合成及构效关系:四唑 C5 位的微小修饰显著影响体内抗肿瘤活性。
J Inorg Biochem. 2019 Mar;192:82-86. doi: 10.1016/j.jinorgbio.2018.12.009. Epub 2018 Dec 23.
7
Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses.结直肠癌患者血红蛋白-奥沙利铂复合物的质谱研究及其与化疗反应的潜在关联。
Rapid Commun Mass Spectrom. 2006;20(17):2533-8. doi: 10.1002/rcm.2622.
8
Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.载奥沙利铂胶束可消除结直肠癌中的肿瘤干细胞样细胞和肿瘤细胞群体。
Int J Nanomedicine. 2011;6:3207-18. doi: 10.2147/IJN.S26268. Epub 2011 Dec 6.
9
Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.奥沙利铂在较低细胞摄取水平时比顺铂具有更高的细胞毒性和 DNA 交联诱导作用,在结直肠癌细胞系中。
Anticancer Drugs. 2012 Nov;23(10):1032-8. doi: 10.1097/CAD.0b013e328355076f.
10
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.影响人大肠肿瘤细胞系对抗肿瘤铂类衍生物敏感性的因素。
Cancer Chemother Pharmacol. 2008 Sep;62(4):577-84. doi: 10.1007/s00280-007-0640-3. Epub 2007 Nov 21.

引用本文的文献

1
Upregulated OCT3 has the potential to improve the survival of colorectal cancer patients treated with (m)FOLFOX6 adjuvant chemotherapy.OCT3 上调有可能改善接受(m)FOLFOX6 辅助化疗的结直肠癌患者的生存。
Int J Colorectal Dis. 2019 Dec;34(12):2151-2159. doi: 10.1007/s00384-019-03407-x. Epub 2019 Nov 16.
2
Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular Level.铂类药物与索拉非尼在细胞水平上的转运体介导的相互作用。
AAPS J. 2017 Nov 30;20(1):9. doi: 10.1208/s12248-017-0169-2.
3
A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells.

本文引用的文献

1
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.新型双(羧基)二氯二乙胺合铂(IV)配合物的合成与表征,其细胞毒性高于顺铂。
Eur J Med Chem. 2011 Nov;46(11):5456-64. doi: 10.1016/j.ejmech.2011.09.006. Epub 2011 Sep 8.
2
Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?提高亲脂性作为克服铂类化合物耐药性的策略?
J Inorg Biochem. 2011 May;105(5):709-17. doi: 10.1016/j.jinorgbio.2011.02.005. Epub 2011 Feb 19.
3
Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes.
一种强效葡萄糖-铂共轭物利用葡萄糖转运蛋白并优先在癌细胞中积累。
Angew Chem Int Ed Engl. 2016 Feb 12;55(7):2550-4. doi: 10.1002/anie.201510551. Epub 2016 Jan 8.
通过抗癌铂(IV)配合物的结构变化来调节亲脂性和细胞毒性效力。
J Inorg Biochem. 2011 Jan;105(1):46-51. doi: 10.1016/j.jinorgbio.2010.09.006. Epub 2010 Oct 1.
4
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.细胞蓄积在决定对铂类化疗药物敏感性方面的作用。
Annu Rev Pharmacol Toxicol. 2008;48:495-535. doi: 10.1146/annurev.pharmtox.48.080907.180426.
5
Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake.大量多样的抗癌铂配合物数据集的亲脂性计算及其与细胞摄取的关系。
J Med Chem. 2007 Oct 18;50(21):5227-37. doi: 10.1021/jm0708275. Epub 2007 Sep 27.
6
New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.在铂配位球中同时含有O,O'-螯合乙酰丙酮配体和硫配体的新型铂(II)配合物可诱导人宫颈癌HeLa细胞凋亡。
Biochem Pharmacol. 2007 Jun 30;74(1):28-40. doi: 10.1016/j.bcp.2007.03.027. Epub 2007 Mar 31.
7
Mechanisms of resistance to cisplatin and carboplatin.顺铂和卡铂的耐药机制。
Crit Rev Oncol Hematol. 2007 Jul;63(1):12-31. doi: 10.1016/j.critrevonc.2007.02.001. Epub 2007 Mar 1.
8
The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.不同螯合离去基团对单核Pt(II)(1,2-反式-R,R-二氨基环己烷)(X-Y)配合物取代动力学的影响。
J Biol Inorg Chem. 2007 May;12(4):461-75. doi: 10.1007/s00775-006-0200-z. Epub 2007 Jan 24.
9
Organic cation transporters are determinants of oxaliplatin cytotoxicity.有机阳离子转运体是奥沙利铂细胞毒性的决定因素。
Cancer Res. 2006 Sep 1;66(17):8847-57. doi: 10.1158/0008-5472.CAN-06-0769.
10
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).顺铂和奥沙利铂是人类有机阳离子转运体(SLC22A1 - 3以及多药和毒素外排家族)的底物,但卡铂和奈达铂不是。
J Pharmacol Exp Ther. 2006 Nov;319(2):879-86. doi: 10.1124/jpet.106.110346. Epub 2006 Aug 16.